These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 18940531
1. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. J Am Coll Cardiol; 2008 Oct 21; 52(17):1402-9. PubMed ID: 18940531 [Abstract] [Full Text] [Related]
3. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP. J Am Coll Cardiol; 2012 Apr 24; 59(17):1509-18. PubMed ID: 22405632 [Abstract] [Full Text] [Related]
4. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities. Becker M, Altiok E, Ocklenburg C, Krings R, Adams D, Lysansky M, Vogel B, Schauerte P, Knackstedt C, Hoffmann R. JACC Cardiovasc Imaging; 2010 May 24; 3(5):472-81. PubMed ID: 20466342 [Abstract] [Full Text] [Related]
8. The association of left ventricular lead position related to regional scar by speckle-tracking echocardiography with clinical outcomes in patients receiving cardiac resynchronization therapy. Sade LE, Saba S, Marek JJ, Onishi T, Schwartzman D, Adelstein EC, Soman P, Gorcsan J. J Am Soc Echocardiogr; 2014 Jun 24; 27(6):648-56. PubMed ID: 24637058 [Abstract] [Full Text] [Related]
9. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy. Kristiansen HM, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. Eur Heart J Cardiovasc Imaging; 2012 Dec 24; 13(12):991-1000. PubMed ID: 22677455 [Abstract] [Full Text] [Related]
10. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. J Am Coll Cardiol; 2009 Feb 10; 53(6):483-90. PubMed ID: 19195605 [Abstract] [Full Text] [Related]
11. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position. Becker M, Zwicker C, Kaminski M, Napp A, Altiok E, Ocklenburg C, Friedman Z, Adam D, Schauerte P, Marx N, Hoffmann R. JACC Cardiovasc Imaging; 2011 Apr 10; 4(4):366-74. PubMed ID: 21492811 [Abstract] [Full Text] [Related]
12. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads. Rickard J, Johnston DR, Price J, Tedford R, Baranowski B, Bassiouny M, Cantillon D, Grimm RA, Tang WHW, Varma N, Wilkoff BL. Heart Rhythm; 2015 Mar 10; 12(3):517-523. PubMed ID: 25460866 [Abstract] [Full Text] [Related]
13. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, Wilkoff BL, Thomas JD, Grimm RA. Am J Cardiol; 2006 Jun 01; 97(11):1615-21. PubMed ID: 16728225 [Abstract] [Full Text] [Related]